Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14682272 | 0.82 | — | — | |
| SCHEMBL2562647 | 0.79 | CYBB (0.32) | — | |
| SCHEMBL15214740 | 0.79 | CYBB (0.32) | — | |
| SCHEMBL2562384 | 0.79 | CACNB4 (0.35) | — | |
| SCHEMBL4601117 | 0.76 | POLB (0.33) | — | |
| SCHEMBL10098744 | 0.75 | — | — | |
| SCHEMBL437166 | 0.70 | SLC6A2 (0.32) | CYP3A4TSHRPIK3CA | |
| SCHEMBL12855001 | 0.63 | MEN1 (0.33) | TSHR | |
| SCHEMBL13070891 | 0.62 | — | — | |
| SCHEMBL9267056 | 0.61 | SLC6A2 (0.31) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680337-B2 | Process for the production of amides | Sungenta Limited (GB) | 2014-03-25 | — | — | US | disclosed |
| EP-2253623-B1 | New crystal form of a pyrazole fungicide | SYNGENTA PARTICIPATIONS AG (CH) | 2013-10-23 | — | — | EP | disclosed |
| US-20130253225-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | SYNGENTA LIMITED (GB) | 2013-09-26 | — | — | US | disclosed |
| US-8436037-B2 | Process for the production of amides | SYNGENTA LIMITED (GB) | 2013-05-07 | — | — | US | disclosed |
| US-20120065239-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | SYNGENTA LIMITED (GB) | 2012-03-15 | — | — | US | disclosed |
| US-7994341-B2 | Process for the production of amides | SYNGENTA LIMITED (GB) | 2011-08-09 | — | — | US | disclosed |
| US-20090163569-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | SYNGENTA CROP PROTECTION, INC. (US) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065239-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | CFH, C5, CFB | CYP3A4 332/4885TSHR 77/4885PIK3CA 1101/4885 |
| US-20130253225-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | CFH, C5, CFB | CYP3A4 389/4885TSHR 92/4885PIK3CA 959/4885 |
| US-20090163569-A1 | PROCESS FOR THE PRODUCTION OF AMIDES | C5, CFH, C9 | CYP3A4 287/4885TSHR 89/4885PIK3CA 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.